EyePoint Pharmaceuticals (NASDAQ:EYPT) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. Insights from analysts’ 12-month price targets are revealed, presenting an average target of $29.75, a high estimate of $32.00, and a low estimate of $28.00. This current average represents a 4.8% decrease from the previous average price target of $31.25. Decoding Analyst Ratings:…